TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 DKK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover | 543 | 355 | |
Financial expenses | 297 | 3 | |
Earnings before taxes | 48 | -66 | |
EBITDA | 337 | -81 | |
Total assets | 10,549 | 11,217 | |
Current assets | 651 | 513 | |
Current liabilities | 189 | 121 | |
Equity capital | 10,277 | 10,997 | |
- share capital | 70 | 73 | |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency | 97.4% | 98.0% | |
Turnover per employee | 543 | 355 | |
Profit as a percentage of turnover | 8.8% | -18.6% | |
Return on assets (ROA) | 3.3% | -0.6% | |
Current ratio | 344.4% | 424.0% | |
Return on equity (ROE) | 0.5% | -0.6% | |
Change turnover | 207 | -88 | |
Change turnover % | 62% | 61% | -20% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.